specialty manufacturing in Texas and a next-generation manufacturing plant for biologics in Maryland, according to the drugmaker. While AstraZeneca's U.S. operations generate around 43% of its ...

LONDON, Feb 27 (Reuters) - AstraZeneca has opened a plant to produce biogas from organic waste that will ensure by the end of this year all of its research and development and drug manufacturing ...

Controlling the entire cell therapy production process—from material receipt to product release—is “essential,” according to AstraZeneca, which says its new $300 million manufacturing facility will be ...

LONDON — Pharmaceutical company AstraZeneca on Friday cancelled a planned 450 million-pound ($560 million) investment in a vaccine manufacturing plant in northwest England, blaming the new ...

AstraZeneca established its vaccines unit after collaborating with the University of Oxford to develop a COVID-19 vaccine. The existing site, currently used for producing the nasal flu vaccine ...

Assemblin has been tasked with an upgrade of AstraZeneca's Gärtuna production plant in Södertälje, Sweden. The project entails multi-technical installations and general construction ...

The Financial Times leads on AstraZeneca's decision to scrap plans for a new vaccine manufacturing plant in Liverpool, calling it "a blow to the government's growth agenda". The paper says ...

“Several factors have influenced this decision, including the timing and reduction of the final offer compared to the previous government’s proposal,” read a statement by AstraZeneca.

AstraZeneca has cancelled a planned £450 million investment in a vaccine manufacturing plant in Merseyside, saying Labour failed to match the previous government’s offer of support. The ...

AstraZeneca's plan to invest £450 million ($578 million) in a vaccines manufacturing plant in the UK has been thrown into doubt, claims a report in the Financial Times. The Treasury, under new ...

AstraZeneca has scrapped plans to invest £450m in expanding a vaccine manufacturing plant in Merseyside, blaming a reduction in government support. The pharmaceutical giant announced its decision ...